National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: HPV Vaccine
< Back to Main
In English En español
    Posted: 06/02/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
PowerPoint Version  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Slide 3 : Low-Risk and High-Risk HPVs previousnext

There are three groups of genital HPV strains: many no-risk types cause neither warts nor cancer; a few types cause genital warts; and 15 or so high-risk types can increase one's risk of cancer.

If left untreated, genital warts do not turn into cancer.

High-risk HPV, on the other hand, may trigger an infection that leads to cervical cancer. The majority of infections with high-risk HPVs clear up on their own. Some infections persist without causing any additional abnormal cell changes. However, a few infections caused by high-risk HPVs end up triggering cervical cancer over many years.

Low-Risk and High-Risk HPVs

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov